每經AI快訊(xun)，九(jiu)洲藥業1月(yue)(yue)8日(ri)晚間發布公(gong)(gong)(gong)告稱，浙(zhe)(zhe)江(jiang)九(jiu)洲藥業股(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)于2024年1月(yue)(yue)4日(ri)召開第八屆董事會第二次(ci)會議(yi)，會議(yi)審議(yi)通過(guo)了《關于以(yi)集中(zhong)競價交(jiao)易方(fang)式回(hui)購(gou)公(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)份(fen)的議(yi)案》。現(xian)將公(gong)(gong)(gong)司(si)(si)(si)2024年1月(yue)(yue)4日(ri)前(qian)十大無限(xian)(xian)(xian)售條件股(gu)(gu)東(dong)披露如(ru)下：浙(zhe)(zhe)江(jiang)中(zhong)貝九(jiu)洲集團有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)持(chi)約(yue)(yue)2.84億股(gu)(gu)，占(zhan)比(bi)(bi)31.57%；中(zhong)國(guo)工(gong)商銀(yin)(yin)行(xing)(xing)股(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)－中(zhong)歐醫(yi)(yi)療(liao)健康混合型證券(quan)(quan)投資(zi)基金(jin)持(chi)約(yue)(yue)4406萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)4.91%；臺州市歌德實業有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)持(chi)約(yue)(yue)4059萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)4.52%；花(hua)莉蓉持(chi)約(yue)(yue)3190萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)3.55%；中(zhong)國(guo)工(gong)商銀(yin)(yin)行(xing)(xing)股(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)－中(zhong)歐醫(yi)(yi)療(liao)創新股(gu)(gu)票(piao)型證券(quan)(quan)投資(zi)基金(jin)持(chi)約(yue)(yue)2214萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)2.46%；林輝潞持(chi)約(yue)(yue)1748萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)1.95%；中(zhong)國(guo)銀(yin)(yin)行(xing)(xing)股(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)－華(hua)寶中(zhong)證醫(yi)(yi)療(liao)交(jiao)易型開放式指數證券(quan)(quan)投資(zi)基金(jin)持(chi)約(yue)(yue)1606萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)1.79%；香港(gang)中(zhong)央結算有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)持(chi)約(yue)(yue)1377萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)1.53%；羅月(yue)(yue)芳持(chi)約(yue)(yue)1207萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)1.34%；中(zhong)國(guo)建設銀(yin)(yin)行(xing)(xing)股(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)－工(gong)銀(yin)(yin)瑞信前(qian)沿(yan)醫(yi)(yi)療(liao)股(gu)(gu)票(piao)型證券(quan)(quan)投資(zi)基金(jin)持(chi)1000萬(wan)股(gu)(gu)，占(zhan)比(bi)(bi)1.11%。前(qian)十大流通股(gu)(gu)東(dong)合計持(chi)股(gu)(gu)約(yue)(yue)4.92億股(gu)(gu)，占(zhan)比(bi)(bi)54.73%。

九洲藥業(ye)的董事(shi)長是花(hua)莉(li)蓉，女(nv)，55歲，學(xue)歷背(bei)景為(wei)碩士(shi)；總經(jing)理是梅義(yi)將(jiang)，男(nan)，48歲，學(xue)歷背(bei)景為(wei)本科。

每經頭條（nbdtoutiao）——

(記者 曾健輝)

免責聲明：本文內容(rong)與數(shu)據僅供參考，不構成投資建(jian)議，使用(yong)前請核(he)實(shi)。據此操作，風險自擔。